Literature DB >> 3284877

Effect of tyrosine on attention deficit disorder with hyperactivity.

J Eisenberg1, G M Asnis, H M van Praag, R M Vela.   

Abstract

A single-blind study was conducted to evaluate the effect of oral tyrosine on attention deficit disorder (ADD) with hyperactivity in seven outpatient children. Since most biological evidence of ADD supports a norepinephrine or dopamine deficiency, the authors hypothesized that tyrosine, which has been shown to increase catecholamine synthesis, would be beneficial in the treatment of ADD. None of the subjects, however, showed any significant improvement with tyrosine. Implications for the catecholamine deficiency hypothesis and treatment strategies for ADD are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284877

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

Authors:  Rachel A Cliburn; Amy R Dunn; Kristen A Stout; Carlie A Hoffman; Kelly M Lohr; Alison I Bernstein; Emily J Winokur; James Burkett; Yvonne Schmitz; William M Caudle; Gary W Miller
Journal:  J Chem Neuroanat       Date:  2016-11-09       Impact factor: 3.052

Review 2.  Risks and benefits of drugs used in the management of the hyperactive child.

Authors:  A M Fox; M J Rieder
Journal:  Drug Saf       Date:  1993-07       Impact factor: 5.606

3.  Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo.

Authors:  Kelly M Lohr; Alison I Bernstein; Kristen A Stout; Amy R Dunn; Carlos R Lazo; Shawn P Alter; Minzheng Wang; Yingjie Li; Xueliang Fan; Ellen J Hess; Hong Yi; Laura M Vecchio; David S Goldstein; Thomas S Guillot; Ali Salahpour; Gary W Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.